Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Shengtai Pharma Begins FY2009 with Small Drop

publication date: Nov 14, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Shengtai Pharmaceutical, Inc. reported that the August Olympics caused a slowdown in its fiscal year 2009 Q1 (ended September 30, 2008) financial performance. The government restrictions on manufacturing and transportation, put in place in Beijing to reduce pollution, disrupted normal business activity. As a result, Shengtai reported that Q1 revenues were 6% lower at $18 million, while net income fell a more serious 72% to $630,000. More details...

Stock Symbol: (OTCBB: SGTI)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...